Contrast-enhanced ultrasound with microbubbles will localize the same axillary lymph node as Technetium-99m nanocolloid.
ID
Bron
Verkorte titel
Aandoening
Breast cancer, sentinel lymph node localization
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Detection rate of microbubble-enhanced Iodine-125 seed localization of SLN, defined as the number of patients in whom the microbubble-enhanced SLN and the Tc-99m enhanced SNL are the same.
Achtergrond van het onderzoek
Preoperative work-up for breast surgery and sentinel lymph node (SLN) biopsy is logistically complicated. On the day of surgery, patients spend hours at imaging departments and operating theatres are forced to keep flexible time schedules. Microbubble-enhanced Iodine-125 seed localization has the potential to allow localization of the SLN days or weeks before surgery. With the current study, we aim to evaluate whether microbubble localization of the SLN is a reliable alternative for the standard technetium-99m enhanced SLN localization and subsequent SLN biopsy. If the microbubble technique turns out to be an accurate alternative, logistics and waiting time on the day of surgery will be improved, which would be of great benefit for the patient.
Doel van het onderzoek
Contrast-enhanced ultrasound with microbubbles will localize the same axillary lymph node as Technetium-99m nanocolloid.
Onderzoeksopzet
SLN localization with microbubbles, Iodine-125 seed placement and SPECT/CT scan.
Onderzoeksproduct en/of interventie
Preoperative contrast-enhanced ulterasound with microbubble contrast for localization of axillary lymph node(s) localization with subsequent placement of an Iodine-125 seed will be compared to 'standard sentinel lymph node localization'. Both techniques will be applied in all study patients.
Algemeen / deelnemers
Room E.01.132<br>
University Medical Center Utrecht<br>
PO Box 85500
M.W. Barentsz
Utrecht 3508 GA
The Netherlands
+31 (0)88 7550054
m.barentsz@umcutrecht.nl
Wetenschappers
Room E.01.132<br>
University Medical Center Utrecht<br>
PO Box 85500
M.W. Barentsz
Utrecht 3508 GA
The Netherlands
+31 (0)88 7550054
m.barentsz@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Females, aged 18 years or older;
2. Histologically confirmed invasive carcinoma or patients with in situ breast cancer with indication for SLN biopsy.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Male patients;
2. Histologically or cytologically proven axillary lymph node involvement;
3. Recurrent disease;
4. Indication for ALND;
5. Pregnancy or lactation;
6. Sentinel lymph node biopsy after neoadjuvant treatment;
7. Recent acute coronary syndrome or unstable ischemic heart disease*;
8. Severe lung disease* and shortness of breath;
9. Unstable neurologic disease, acute endocarditis, artificial heart valves, acute systemic infection, tromboembolic disease, advanced liver or kidney failure;
10. Mentally incompetent patients.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL3535 |
| NTR-old | NTR3690 |
| CCMO | NL38677.041.12 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |
| OMON | NL-OMON37670 |
Samenvatting resultaten
2) Sever AR, Mills P, Jones SE, Cox K, Weeks J, Fish D, Jones PA. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. AJR Am J Roentgenol. 2011 Feb;196(2):251-6.